What Is NAMA Recovery?

The National Alliance for Medication Assisted Recovery (NAMA-R) is an organization of medication assisted treatment (MAT) patients, healthcare professionals, friends, and associates working together for greater public understanding and acceptance of MAT.

Promoting
quality MAT as the most effective modality for the treatment of opiate dependence.

NAMA-R’s Goals

  • To eliminate discrimination toward MAT patients
  • To create a more positive image about MAT
  • To help preserve patients’ dignity and their rights
  • To make treatment available on demand to every person who needs it
  • To empower MAT patients with a strong public voice

Struggling
to destigmatize the treatment which has given us back our lives.

At NAMA-R, we’d like people to focus on the success stories of MAT: patients who became successful lawyers or construction workers, patients who rebuilt their families and are now productive members of society.  There are thousands of us.

What We Are NOT!

Working
to dispel the ignorance regarding MAT which plagues
both treatment professionals and the general public.

NAMA-R is not an organization of apologists for what passes for MAT in the United States today and abroad. Most Opiate Treatment Programs (OTP) do not even come close to practicing the treatment modality created by Drs Dole and Nyswander five decades ago, and even the best programs are severely hampered by senseless regulation and by the presence of staff oriented towards non-medical modalities. NAMA-R believes that only through education can MAT fulfill its promise and again become the most effective, progressive, and humane treatment for opioid dependence.

Since its beginning over fifty years ago, MAT has proven to be the most effective treatment for opiate addiction, resulting in the termination of both drug use and criminal behavior. In spite of this success, MAT is often disparaged as a “substitute drug” by those who ignore the positive benefits it has brought to society. The media tends to focus on the negatives and none of the success stories.

These negative attitudes impair the effectiveness of OTPs. Patients are mistreated, misinformed and stigmatized. They are victims of discrimination in health care, the job market, education, insurance, and housing. Even treatment professionals feel ashamed to admit they work in this field.

Fighting
discrimination perpetrated against MAT patients.

Changing People’s Views With Education and Advocacy NAMA-R will:

  • Speak publicly about the productive lives led by MAT patients
  • Establish contact with elected and appointed officials
  • Attend community meetings
  • Prepare and distribute educational material
  • Participate in media interviews
  • Create a unified voice to reach the public on all issues of concern to MAT patients

In addition to fighting the negative image and low self-esteem of MAT patients, NAMA-R provides practical assistance in the everyday concerns of patients and treatment professionals.

Drug Treatment

Some OTPs have become huge, cumbersome bureaucracies. The policies of various agencies often conflict with one another, leaving the patient frustrated and discouraged. NAMA-R helps promote improved program services, development of new approaches, and increased patient participation in treatment.

Treatment on Demand

Opiate addicts seeking help are daily denied treatment and forced back to the streets because of long waiting lists at clinics. NAMA-R can push for immediate expansion of treatment and provide referral assistance to those who need help getting into a program.

Education of MAT Patients

In many programs, the fundamentals of MAT and addiction are not even explained to patients. As a result, many believe dangerous folklore about methadone such as “it gets in your bones” or “it rots your teeth”. NAMA-R remedies this situation with workshops, meetings, the media and other methods.

Some treatment professionals lack an understanding of the pharmacology of addiction and how this relates to rehabilitation. NAMA-R promotes an improved addiction treatment curriculum in institutions of higher learning.

AIDS and Hepatitis

Patients that are infected with HIV+ and HCV+ need information to promore a healthy lifestyle. Information on preventative healthcare for non-HIV/HCV patients also needs improving. NAMA-R helps supplement existing Infectious Disease Education Programs.

Discrimination

Discrimination is a major obstacle for anyone who has ever used drugs. While some legislation has been enacted which protects former addicts and MAT patients, there still remain many areas where MAT patients are not protected. NAMA-R works to inform MAT patients of their rights and to provide support to those who have been victims of discrimination.

Notes

In 2009 at the AATOD conference in New York the Board of Directors of the National Alliance of Methadone Advocates, the premier patient advocacy organization in the opiate addiction recovery community, established in 1988 in this very city, announces an important change to its identity. It will now be doing business as the National Alliance for Medication Assisted Recovery, or NAMA Recovery. You can read more about the change at the President’s Blog.

National Alliance for Medication Assisted Recovery

435 Second Avenue

New York,NY   10010

Phone/Fax: (212) 595-NAMA (6262)

Add Your Voice!

Support Our Work!

Similar Posts

  • Office Based Opioid Treatment Basic Information for Physicians About Buprenorphine

    Admin 01/08/2023

    Office Based Opioid Treatment Basic Information for Physicians About Buprenorphine   Federal Law Code of Federal Regulations. Confidentiality of Alcohol and Drug Abuse Patient Records. 42 CRF Part 2. Read PDF File Document. Public Law 106-310, 106th Congress. Sec. 3502. Controlled Substances Act, October 17, 2000. Full Law Basic Information About DATA:On October 17, 2000…

  • Methadone Medical Maintenance

    Admin 10/22/2022

    Policy Statement Number 1 April 1994 The National Alliance of Methadone Advocates supports the concept of Medical Maintenance and the prescribing of methadone outside of the methadone clinic setting. Medical Maintenance was initially implemented for patients who had achieved a high level of functionally in society and were hindered by the regulations that were conceived…

  • Nominations Open for the 2022 Richard Lane/Robert Holden Advocacy Award!

    Admin 03/06/2023

    Nominations Open for the 2022 Richard Lane/Robert Holden Advocacy Award! NAMA Recovery    AATOD Lane Holden Award    May 1, 2022  |  0 Richard Lane was a long-term heroin user who, upon release from prison in 1967, was instrumental in establishing one of the Nation’s first opioid treatment programs. In 1974, he became the Executive…

  • Membership Application

    Admin 11/15/2021

    Send To: National Alliance of Methadone Advocates Inc.                                                                                                     Back To NAMA Home Page NAMA Membership Office 435 Second Avenue New York, NY 11000 Membership Application Name:   _______________________________________________________  Organization:  ________________________________________________________________________ Title:  ________________________________________________________ Degree(s):__________________________ Address:  ________________________________________________________________________ Address:  ________________________________________________________________________ City:   _____________________________________    State:   ______Postal Code:   ________Country:   ___ Home Phone: (___)__________________________   Work Phone:   (___)______________________    Alternate Phone:(___)________________________Fax:   (___)______________________________       Email:______________________________________ If you have email may we send you…

  • Focus On

    Admin 09/16/2021

    Issues To Focus On LAAM Manufacture to Be Discontinued August 23, 2003 Washington, D.C. Roxanne the manufacturer of LAAM has informed the FDA that manufacture of the medication is being discontinued. Distribution will continue until the inventory is depleted. Roxanne estimates this to be in early January 2004. The reason for the action is the…

  • Doctors Still Waiting to Test Buprenorphine’s Promise

    Admin 05/08/2022

    Join Together Online January 21, 2003 While 616 physicians nationwide are now authorized to prescribe buprenorphine, its widespread use is still an issue, the Baltimore Sun reported on January 15. Product availability is the first problem. Despite receiving FDA approval in October, the manufacturer did not ship the product to pharmaceutical warehouses until last week….